Physician profile
Suja Mathai
NPI 1356518187
$4,649.64
in general payments reported to CMS, 2019-2025
17 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what 80% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $345 · 2021: $302 · 2022: $763 · 2023: $614 · 2024: $879 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,615.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,179.48 | 2019-2025 | Biktarvy, Yeztugo |
| Organogenesis INC. | $868.18 | 2019-2025 | Puraply Wound Matrix, Affinity, Apligraf |
| Viiv Healthcare Company | $710.14 | 2019-2025 | Dovato, Cabenuva, Apretude |
| Abbvie INC. | $441.39 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $322.76 | 2019-2025 | Dificid, Zerbaxa, Recarbrio |
| Paratek Pharmaceuticals, INC. | $296.81 | 2020-2025 | Nuzyra |
| Insmed, INC. | $155.44 | 2019-2025 | Arikayce |
| Smith+Nephew, INC. | $145.06 | 2019-2023 | Grafix Pl, Oasis, Stravix Pl |
| Allergan, INC. | $112.22 | 2019-2020 | |
| Melinta Therapeutics, LLC | $99.40 | 2019-2022 | |
| Aimmune Therapeutics, INC. | $84.15 | 2024-2025 | Vowst |
| Shionogi INC | $72.05 | 2024-2025 | Fetroja |
| Theratechnologies INC. | $69.73 | 2020-2025 | Trogarzo, Egrifta |
| Janssen Biotech, INC. | $43.54 | 2019-2023 | Symtuza |
| Hologic Sales and Service, LLC | $17.93 | 2025 | Aptima |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $16.36 | 2024 | Xarelto |
| Sanofi Pasteur INC. | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suja Mathai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.